{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000078","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.487790+00:00","generated_at":"2026-05-17T23:42:32.819344+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Salarius amends Decoy merger: removes $2M threshold, changes conversion price adjustment","bullets":["Fourth Amendment dated July 29, 2025 removes $2M threshold for 'subsequent financing' triggering conversion adjustment.","Conversion price adjustment changes from weighted average to actual per share offering price in subsequent financings.","One-year limitation on conversion ratio adjustments eliminated; adjustments apply until stockholder approval and Nasdaq listing standards met.","Amendments intended to induce holders of Decoy convertible/non-convertible notes to consent and convert."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000078","json":"https://secwatch.observer/filing/0001615219-25-000078.json","markdown":"https://secwatch.observer/filing/0001615219-25-000078.md","text":"https://secwatch.observer/filing/0001615219-25-000078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000078/0001615219-25-000078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000078/flks-20250729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:42:32.819344+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}